Medical Management of Symptomatic Fibroids: Worth It?
作者信息
Hegde Chandrashekhar V
机构信息
Mumbai, India.
出版信息
J Obstet Gynaecol India. 2017 Aug;67(4):233-236. doi: 10.1007/s13224-017-1020-5. Epub 2017 Jun 10.
Abstract
摘要
相似文献
1
Medical Management of Symptomatic Fibroids: Worth It?有症状子宫肌瘤的药物治疗：值得吗？
J Obstet Gynaecol India. 2017 Aug;67(4):233-236. doi: 10.1007/s13224-017-1020-5. Epub 2017 Jun 10.
2
The management of uterine leiomyomas.子宫平滑肌瘤的管理
J Obstet Gynaecol Can. 2003 May;25(5):396-418; quiz 419-22.
3
The management of uterine leiomyomas.子宫平滑肌瘤的管理
J Obstet Gynaecol Can. 2015 Feb;37(2):157-178. doi: 10.1016/S1701-2163(15)30338-8.
4
Therapeutic management of uterine fibroid tumors: updated French guidelines.子宫纤维瘤肿瘤的治疗管理：法国更新指南。
Eur J Obstet Gynecol Reprod Biol. 2012 Dec;165(2):156-64. doi: 10.1016/j.ejogrb.2012.07.030. Epub 2012 Aug 29.
5
Ulipristal acetate for use in moderate to severe symptoms of uterine fibroids.醋酸乌利司他用于治疗中重度子宫肌瘤症状。
Womens Health (Lond). 2014 Nov;10(6):565-70. doi: 10.2217/whe.14.60.
6
Tailor management to the patient with fibroids.根据子宫肌瘤患者的情况进行个体化管理。
Practitioner. 2017 Mar;261(1802):19-22.
7
EMAS position statement: management of uterine fibroids.欧洲更年期与男性更年期协会立场声明：子宫肌瘤的管理
Maturitas. 2014 Sep;79(1):106-16. doi: 10.1016/j.maturitas.2014.06.002. Epub 2014 Jun 9.
8
Impact of uterine fibroids on quality of life: a national cross-sectional survey.子宫肌瘤对生活质量的影响：一项全国性横断面调查。
Eur J Obstet Gynecol Reprod Biol. 2018 Oct;229:32-37. doi: 10.1016/j.ejogrb.2018.07.032. Epub 2018 Aug 1.
9
Combining the uterine depletion procedure and myomectomy may be useful for treating symptomatic fibroids.联合子宫切除术和子宫肌瘤切除术可能对治疗有症状的子宫肌瘤有用。
Fertil Steril. 2004 Jul;82(1):205-10. doi: 10.1016/j.fertnstert.2004.01.026.
10
Electromagnetic image guidance in gynecology: prospective study of a new laparoscopic imaging and targeting technique for the treatment of symptomatic uterine fibroids.妇科中的电磁图像引导：一种用于治疗有症状子宫肌瘤的新型腹腔镜成像与靶向技术的前瞻性研究。
Biomed Eng Online. 2015 Oct 15;14:90. doi: 10.1186/s12938-015-0086-5.
本文引用的文献
1
Uterine fibroid shrinkage after short-term use of selective progesterone receptor modulator or gonadotropin-releasing hormone agonist.短期使用选择性孕激素受体调节剂或促性腺激素释放激素激动剂后子宫肌瘤的缩小
Obstet Gynecol Sci. 2017 Jan;60(1):69-73. doi: 10.5468/ogs.2017.60.1.69. Epub 2017 Jan 19.
2
Different dosages of mifepristone versus enantone to treat uterine fibroids: A multicenter randomized controlled trial.不同剂量米非司酮与炔诺酮治疗子宫肌瘤的多中心随机对照试验。
Medicine (Baltimore). 2017 Feb;96(7):e6124. doi: 10.1097/MD.0000000000006124.
3
Ulipristal acetate for pre-operative treatment of moderate-to-severe uterine fibroids in women of reproductive age in The Netherlands: cost minimization analysis and budget impact analysis.醋酸乌利司他用于荷兰育龄期女性中重度子宫肌瘤的术前治疗：成本最小化分析和预算影响分析
J Med Econ. 2017 Mar;20(3):280-287. doi: 10.1080/13696998.2016.1254090. Epub 2016 Nov 11.
4
Long-term medical management of uterine fibroids with ulipristal acetate.醋酸乌利司他治疗子宫肌瘤的长期医学管理。
Fertil Steril. 2016 Jan;105(1):165-173.e4. doi: 10.1016/j.fertnstert.2015.09.032. Epub 2015 Oct 23.
5
Incorporating ulipristal acetate in the care of symptomatic uterine fibroids: a Canadian cost-utility analysis of pharmacotherapy management.将醋酸乌利司他纳入有症状子宫肌瘤的护理：加拿大药物治疗管理的成本效用分析
Clinicoecon Outcomes Res. 2015 Apr 17;7:213-25. doi: 10.2147/CEOR.S78115. eCollection 2015.
6
First series of 18 pregnancies after ulipristal acetate treatment for uterine fibroids.子宫纤维瘤采用醋酸乌利司他治疗后的 18 例妊娠首例系列报道。
Fertil Steril. 2014 Nov;102(5):1404-9. doi: 10.1016/j.fertnstert.2014.07.1253. Epub 2014 Sep 17.
7
Long-term treatment of uterine fibroids with ulipristal acetate ☆.醋酸乌利司他治疗子宫肌瘤的长期疗效观察。
Fertil Steril. 2014 Jun;101(6):1565-73.e1-18. doi: 10.1016/j.fertnstert.2014.02.008. Epub 2014 Mar 12.
8
[Selective progesterone receptor modulator (ulipristal acetate--a new option in the pharmacological treatment of uterine fibroids in women].[选择性孕激素受体调节剂（醋酸乌利司他——女性子宫肌瘤药物治疗的新选择）]
Ginekol Pol. 2013 Mar;84(3):219-22. doi: 10.17772/gp/1567.
9
Endometrial morphology after treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate.治疗子宫肌瘤的选择性孕激素受体调节剂——乌利司他后子宫内膜形态学的变化。
Int J Gynecol Pathol. 2012 Nov;31(6):556-69. doi: 10.1097/PGP.0b013e318251035b.
10
Ulipristal acetate: a novel option for the medical management of symptomatic uterine fibroids.醋酸乌利司他：治疗症状性子宫肌瘤的一种新型医学选择。
Adv Ther. 2012 Aug;29(8):655-63. doi: 10.1007/s12325-012-0042-8. Epub 2012 Aug 16.
Zotero 插件